Entity Common Stock, Shares Outstanding of TG THERAPEUTICS, INC. from Q2 2011 to Q3 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Tg Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and change rate from Q2 2011 to Q3 2025.
  • Tg Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 31 Oct 2025 was 159M shares, a 1.99% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

TG THERAPEUTICS, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 159M +3.09M +1.99% 31 Oct 2025 10-Q 05 Nov 2025
Q2 2025 159M +3.84M +2.48% 05 Aug 2025 10-Q 08 Aug 2025
Q1 2025 157M +2.53M +1.64% 25 Feb 2025 10-K 03 Mar 2025
Q3 2024 156M +4.26M +2.81% 04 Nov 2024 10-Q 07 Nov 2024
Q2 2024 155M +3.85M +2.55% 05 Aug 2024 10-Q 09 Aug 2024
Q1 2024 155M +5.15M +3.45% 02 May 2024 10-Q 06 May 2024
Q3 2023 151M +6.07M +4.18% 01 Nov 2023 10-Q 06 Nov 2023
Q2 2023 151M +5.7M +3.93% 02 Aug 2023 10-Q 04 Aug 2023
Q1 2023 149M +4.96M +3.44% 02 May 2023 10-Q 08 May 2023
Q3 2022 145M +2.4M +1.68% 04 Nov 2022 10-Q 09 Nov 2022
Q2 2022 145M +2.44M +1.71% 02 Aug 2022 10-Q 09 Aug 2022
Q1 2022 144M +2.97M +2.1% 06 May 2022 10-Q 10 May 2022
Q3 2021 143M +11.5M +8.71% 03 Nov 2021 10-Q 08 Nov 2021
Q2 2021 143M +16.2M +12.8% 30 Jul 2021 10-Q 06 Aug 2021
Q1 2021 141M +27.7M +24.4% 04 May 2021 10-Q 10 May 2021
Q3 2020 131M +31.9M +32.1% 04 Nov 2020 10-Q 09 Nov 2020
Q2 2020 127M +31.9M +33.7% 05 Aug 2020 10-Q 10 Aug 2020
Q1 2020 114M +22.9M +25.2% 07 May 2020 10-Q 11 May 2020
Q3 2019 99.6M +16.7M +20.1% 05 Nov 2019 10-Q 12 Nov 2019
Q2 2019 94.8M +11.9M +14.4% 02 Aug 2019 10-Q 09 Aug 2019
Q1 2019 90.8M +15.3M +20.2% 03 May 2019 10-Q 10 May 2019
Q3 2018 82.9M +12.2M +17.3% 05 Nov 2018 10-Q 09 Nov 2018
Q2 2018 82.8M +14M +20.3% 03 Aug 2018 10-Q 09 Aug 2018
Q1 2018 75.6M +18.7M +32.8% 01 Mar 2018 10-K 15 Mar 2018
Q3 2017 70.7M +15.9M +29.1% 01 Nov 2017 10-Q 09 Nov 2017
Q2 2017 68.8M +14.4M +26.4% 01 Aug 2017 10-Q 09 Aug 2017
Q1 2017 56.9M +2.81M +5.2% 01 Mar 2017 10-K 16 Mar 2017
Q3 2016 54.7M +2.21M +4.21% 01 Nov 2016 10-Q 09 Nov 2016
Q2 2016 54.5M +1.91M +3.63% 01 Aug 2016 10-Q 09 Aug 2016
Q1 2016 54.1M +7.55M +16.2% 01 Mar 2016 10-K 15 Mar 2016
Q3 2015 52.5M +8.56M +19.5% 06 Nov 2015 10-Q 09 Nov 2015
Q2 2015 52.5M +14.4M +37.8% 04 Aug 2015 10-Q 10 Aug 2015
Q1 2015 46.5M +12.2M +35.4% 12 Mar 2015 10-K 16 Mar 2015
Q3 2014 44M +10.5M +31.2% 13 Nov 2014 10-Q 14 Nov 2014
Q2 2014 38.1M +4.84M +14.6% 21 Jul 2014 10-Q 24 Jul 2014
Q1 2014 34.4M +8.55M +33.1% 01 Mar 2014 10-K 07 Mar 2014
Q3 2013 33.5M +8.44M +33.7% 01 Nov 2013 10-Q 14 Nov 2013
Q2 2013 33.3M +15.2M +84.3% 29 Jul 2013 10-Q 09 Aug 2013
Q1 2013 25.8M -259M -90.9% 01 Mar 2013 10-K 21 Mar 2013
Q3 2012 25.1M +17.7M +239% 12 Nov 2012 10-Q 14 Nov 2012
Q2 2012 18.1M +15.5M +595% 02 Aug 2012 10-Q/A 07 Sep 2012
Q1 2012 285M 01 Mar 2012 10-K 14 Mar 2012
Q3 2011 7.4M 02 Nov 2011 10-Q 14 Nov 2011
Q2 2011 2.6M 09 Aug 2011 10-Q/A 14 Sep 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.